Takara Bio to Distribute Exiqon Products in Asia

Oct 17, 2012 | staff reporter

NEW YORK (GenomeWeb News) – Takara Bio will distribute Exiqon's miRCURY LNA products in Asia beginning in January 2013, Exiqon announced today.

Takara will market the microRNA research tools in Japan, China, Hong Kong, South Korea, and India. It also will launch research services in the region using Exiqon's products in December 2012.

"Asia is an important growth market where we expect customers will benefit from our combined efforts with Takara Bio to meet customer demand for high-quality research products," Henrik Pfundheller, SVP of sales and marketing for Exiqon, said in a statement.

Financial and other terms of the agreement were not disclosed.

Filed under

Gene Editing, Gene Silencing, & CRISPR

Microarrays & Multiplexing

distribution agreement

RNAi

miRNA

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.